Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial.
Teoh JY, Cheng CH, Tsang CF, Kai-Man Li J, Kwun-Chung Cheng B, Hoi-Chak Chan W, Kwun-Wai Chan W, Churk-Fai Li T, Chiu Y, Law MC, Lok-Hei Leung C, Sze-Ho Ho B, Yue-Kit Lee C, Cheong-Kin Chan R, Shu-Yin Chan E, Chan MT, Hok-Leung Tsu J, Tam HM, Lam KM, So HS, Cho CL, Ng CM, Chan CK, Liu PL, Wing-Hong Chu R, Tsui-Lin Ng A, Chu SK, Yee CH, Yiu MK, Lo KL, Au WH, Ma WK, Ka-Fung Chiu P, Sze-Wan Kwok H, Yip SY, Leung CH, Ng CF; EB-StaR Study Group.
Eur Urol. 2024 Aug;86(2):103-111. doi: 10.1016/j.eururo.2024.04.015. Epub 2024 Apr 30.
Monopolar versus bipolar transurethral resection of bladder Tumour: post-hoc analysis of a prospective trial.
Wong CH, Lim JY, Ko IC, Leung DK, Yuen SK, Yip SY, Ng CF, Teoh JY, Chan ES.
World J Urol. 2024 Aug 2;42(1):466. doi: 10.1007/s00345-024-05124-9.
Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.
Guigui A, Basile G, Zattoni F, Gallioli A, Verri P, Aumatell J, Gondran-Tellier B, Lechevallier E, Bastide C, Uleri A, Sica M, Long-Depaquit T, Dinoi G, Moro FD, Akiki A, Toledano H, Rajwa P, Montorsi F, Amparore D, Porpiglia F, Breda A, Moschini M, Baboudjian M.
World J Urol. 2024 Aug 12;42(1):480. doi: 10.1007/s00345-024-05192-x.
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guerin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study.
Choi J, Kim KH, Kim HS, Yoon HS, Kim JH, Kim JW, Lee YS, Choi SY, Chang IH, Ko YH, Song W, Jeong BC, Nam JK.
Investig Clin Urol. 2024 May;65(3):248-255. doi: 10.4111/icu.20230313.
Efficacy and safety of 2-micron laser versus conventional trans-urethral resection of bladder tumor for non-muscle-invasive bladder tumor: A systematic review and meta-analysis.
Gu J, He Z, Chen Z, Wu H, Ding M.
J Cancer Res Ther. 2022 Dec;18(7):1894-1902. doi: 10.4103/jcrt.jcrt_608_22.
An updated systematic review, meta-analysis, and trial sequential analysis of the efficacy and safety of en bloc transurethral resection vs. conventional transurethral resection for nonmuscle-invasive bladder tumor.
Xu Z, Wang Q, Li B, Hao X, Ren C, Chen X, Liu L, Liu X.
Int J Surg. 2025 Apr 1;111(4):3061-3077. doi: 10.1097/JS9.0000000000002291.
Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.
Zhou L, Liang X, Zhang K.
Aging Male. 2020 Dec;23(5):1182-1193. doi: 10.1080/13685538.2020.1718637. Epub 2020 Feb 5.
Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis.
Yang H, Lin J, Gao P, He Z, Kuang X, Li X, Fu H, Du D.
Urol Int. 2020;104(5-6):402-409. doi: 10.1159/000503734. Epub 2020 Jan 7.
Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials.
Xie K, Cao D, Wei Q, Ren Z, Li J, Li Y, Fu M.
World J Urol. 2021 Apr;39(4):1177-1186. doi: 10.1007/s00345-020-03271-3. Epub 2020 May 27.
Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Lee K, Jeong SH, Yoo SH, Ku JH.
Investig Clin Urol. 2022 Jan;63(1):14-20. doi: 10.4111/icu.20210314.
